Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Menarini Group
DescriptionAnti-idiotype mAb expressed by ovarian cancer cells
Molecular Target
Mechanism of ActionImmunotherapy; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase III
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today